Tag:
Chantix
Latest Headlines
Latest Headlines
CN Creative nails $3.1M for electronic inhaler smoking cessation device
CN Creative has secured $3.1 million in new financing to fund final development work for its electronic inhaler nicotine replacement therapy device to help patients quit smoking. Advent Life Sciences
Study: Chantix unsuitable for first-line use
Pfizer's smoking-cessation drug Chantix (varenicline) is not suitable for first-line use due to its poor safety profile, contradicting a recent FDA review, according to a study appearing in the
FDA: Chantix doesn't boost risk of psych hospitalization
Chantix apparently doesn't boost the risk of psychiatric hospitalization, but it still needs that "black box" warning of psychiatric side effects, the FDA says. After reviewing two studies that
EMA wants Actos warning, weighs in on Chantix
Regulators on both sides of the Atlantic issued a slew of decrees about drug safety, weighing in on everything from flu vaccine to bone drugs to Pfizer's smoking cessation med Chantix. The biggest
Study: Pfizer's Chantix raises heart risks 72%
It's another blow for Pfizer's stop-smoking drug Chantix. A new study found that healthy, middle-aged smokers who use the drug have a higher risk of having a heart attack or developing other serious
FDA: Pfizer's Chantix may boost heart risks
When the safety of Pfizer's stop-smoking drug Chantix is debated, usually the focus is on the drug's potential link to psychiatric side effects. But now U.S. regulators have warned that the drug can
France to stop paying for Pfizer's Champix
France has decided to stop paying for Pfizer's stop-smoking drug Champix. The treatment, sold as Chantix in the U.S., will be pulled from the government formulary of meds eligible for reimbursement
1,200 Chantix cases centralized in AL
More than 1,000 lawsuits over the stop-smoking drug Chantix will come home to roost in an Alabama court. U.S. Judge Inge Johnson will handle pretrial work on 1,200 claims that the Pfizer ( $PFE )
Pfizer bungles tax-fueled Champix surge in Japan
A new cigarette tax and a stop-smoking drug were a match made in Japan, and it might have been heaven if Pfizer ( $PFE ) hadn't fumbled. The drugmaker, which sells its Chantix remedy as Champix in
Pfizer, GSK's stop-smoking meds get warning
Federal regulators have ordered new safety language on the smoking cessation drugs Chantix (varenicline) and Zyban (buproprion). The two meds are getting the toughest warning added to their labels,
